Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -94.47%-61.91K | -273.46%-55.64K | 1.31%-41.42K | -22.47%-46.96K | -82.46%5.3K | 34.28%-31.83K | 119.41%32.08K | -1,522.34%-41.97K | -252.81%-38.34K | 3,205.76%30.19K |
| Net income from continuing operations | -322.40%-483.03K | -17.55%-85.85K | 88.27%-100.53K | 354.73%566.86K | -208.93%-480.01K | 65.60%-114.35K | 50.11%-73.03K | 28.40%-856.75K | -1.15%-222.54K | 14.71%-155.38K |
| Operating gains losses | 1,455.72%349.88K | -42.85%-78.62K | -1,847.13%-491.22K | -937.00%-693.09K | 581.54%282.71K | -135.57%-25.81K | 19.71%-55.04K | -86.74%28.12K | 704.96%82.81K | -38.58%-58.71K |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Other non cashItems | 17.04%20.88K | -27.03%20.57K | -73.21%86.61K | -42.91%20.89K | -77.85%19.68K | -83.04%17.84K | -69.58%28.19K | 8.06%323.34K | -57.63%36.59K | 10.94%88.86K |
| Change In working capital | -44.35%50.35K | -33.11%88.26K | 0.09%463.73K | -30.92%58.38K | 34.80%182.92K | -14.85%90.48K | -3.59%131.95K | -15.11%463.32K | -24.87%84.51K | -5.43%135.7K |
| -Change in receivables | -104.40%-96 | -307.35%-1.39K | 108.66%307 | 47.10%-337 | 60.25%-1.2K | 1,882.73%2.18K | -4,150.00%-340 | -186.55%-3.55K | -142.81%-637 | -213.54%-3.01K |
| -Change in prepaid assets | ---- | ---- | 200.00%11.26K | --0 | 369.13%11.26K | ---- | ---- | -174.07%-11.26K | ---11.26K | --2.4K |
| -Change in payables and accrued expense | -42.87%50.45K | -32.23%89.65K | -5.43%452.16K | -39.09%58.72K | 26.81%172.85K | -18.65%88.3K | -3.34%132.29K | -9.19%478.13K | -13.14%96.41K | -3.21%136.31K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -94.47%-61.91K | -273.46%-55.64K | 1.31%-41.42K | -152.15%-46.96K | -49.43%5.3K | 34.28%-31.83K | 119.41%32.08K | -1,522.34%-41.97K | -71.36%-18.62K | 1,177.16%10.47K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 61.38%-782 | 89.16%-8.11K | -131.19%-153.51K | 174.18%5.33K | -380.86%-81.97K | 83.07%-2.03K | -147.71%-74.84K | 54.52%-66.4K | -329.57%-7.18K | -177.68%-17.05K |
| Net PPE purchase and sale | 61.38%-782 | 89.16%-8.11K | -131.19%-153.51K | 174.18%5.33K | -380.86%-81.97K | 83.07%-2.03K | -147.71%-74.84K | 54.52%-66.4K | -329.57%-7.18K | -177.68%-17.05K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 61.38%-782 | 89.16%-8.11K | -131.19%-153.51K | 174.18%5.33K | -380.86%-81.97K | 83.07%-2.03K | -147.71%-74.84K | 54.52%-66.4K | -329.57%-7.18K | -177.68%-17.05K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 82.69%61.69K | 32.27%63.23K | 81.80%195.76K | 60.14%43.44K | 8,485.56%70.75K | -44.09%33.77K | 147.42%47.8K | 40.41%107.68K | 263.69%27.13K | -82.36%824 |
| Net issuance payments of debt | ---63.23K | 64.17%63.23K | -31.22%37.17K | --0 | ---1.35K | --0 | --38.51K | --54.04K | --27.13K | --0 |
| Net other financing activities | ---- | ---- | 195.68%158.59K | --43.44K | 8,648.79%72.09K | 0.83%33.77K | -51.92%9.29K | -30.06%53.64K | --0 | -82.36%824 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 82.69%61.69K | 32.27%63.23K | 81.80%195.76K | 60.14%43.44K | 8,485.56%70.75K | -44.09%33.77K | 147.42%47.8K | 40.41%107.68K | 263.69%27.13K | -82.36%824 |
| Net cash flow | ||||||||||
| Beginning cash position | -66.54%2.38K | 40.32%2.9K | -25.09%2.07K | 46.42%1.09K | 8.05%7.02K | 9.56%7.11K | -25.09%2.07K | -96.31%2.76K | -75.61%741 | 18.57%6.49K |
| Current changes in cash | -1,020.22%-997 | -110.34%-521 | 220.38%833 | 36.91%1.81K | -3.11%-5.93K | -1,212.50%-89 | 35.19%5.04K | 99.04%-692 | 573.21%1.33K | -135.88%-5.75K |
| End cash Position | -80.32%1.38K | -66.54%2.38K | 40.32%2.9K | 40.32%2.9K | 46.42%1.09K | 8.05%7.02K | 9.56%7.11K | -25.09%2.07K | -25.09%2.07K | -75.61%741 |
| Free cash from | -85.15%-62.69K | -49.07%-63.75K | -79.87%-194.93K | -61.33%-41.63K | -1,065.84%-76.68K | 43.94%-33.86K | -174.26%-42.76K | 27.07%-108.37K | -233.42%-25.8K | 7.51%-6.58K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.